Biologics Market Size, Share, Outlook, Analysis, and Forecast 2018-2026

Biologics Market GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND
OPPORTUNITY ANALYSIS, 2018-2026
REPORT DESCRIPTION
Biologics Market – Overview
The biologics market size is expected to boost owing to the increasing product pipeline from different companies
like Merck and Co., Pfizer, Glaxosmithkline. Pfizer has a strong product pipeline for 2019 of biologics,
biosimilars, vaccines and small molecules. 35 products are in phase 1, 28 are in phase 2 and 26 are in phase 3 and
11 products are in the process of registration. Total 100 products are in trial phase. Most recent approval by Pfizer
is DAURISMO (glasdegib) in U.S. for adult patients with newly-diagnosed acute myeloid leukemia for whom
intensive chemotherapy is not an option.
Furthermore, the biologics market revenue is growing because of increasing number of Food and Drug
Administration (FDA) approvals for new biologic medicines for treatment of rare diseases. For instance, in 2017
US FDA approved 46 biologics and in December 2017, GlaxoSmithKline’s biologic Nucala was approved for the
treatment of a rare disease called eosinophilic granulomatosis, with polyangiitis (EPGA).
Biological products include a wide range of products such as vaccines, blood and blood components, allergenic,
somatic cells, gene therapy, tissues, and recombinant therapeutic proteins. Many biologics are produced using
recombinant DNA technology. Biologics are the best used drugs for genetic disorders. New technologies, novel
therapies are emerging for the manufacturing of new biologics which holds a prominent future for biologics
market.
REPORT DESCRIPTION
Biologics Market Taxonomy:
By Product Type
Monoclonal Antibodies
Vaccines
Recombinant Hormones/Proteins
Cell Therapy
Gene Therapy
By Application
Oncology
Infectious Diseases
Immunology
Autoimmune Diseases
Others
Get Request a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/2663
REPORT DESCRIPTION
Biologics Market – Key Players
AbbVie
Amgen
AstraZeneca
Biogen Idec
Bristol-Myers Squibb,
Eli Lilly and Company
GlaxoSmithKline
Johnson and Johnson
Merck and Co., Merck KGaA
Novartis
Pfizer
F. Hoffmann-La Roche Ltd
Get More Inf @ https://www.coherentmarketinsights.com/ongoing-insight/biologics-market-2663
ABOUT COHERENT MARKET INSIGHTS
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its
plethora of clients achieve transformational growth by helping them make critical business decisions. We are
headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players
from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help
businesses around the globe deliver practical and lasting results through various recommendations about
operational improvements, technologies, emerging market trends and new working methods. We offer both
customized and syndicated market research reports that help our clients create visionary growth plans to
provide traction to their business. We meticulously study emerging trends across various industries at both the
global and regional levels to identify new opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
MARKET INTELLIGENCE SERVICES
CUSTOMIZED RESEARCH
CONSULT STUDIES
SYNDICATED RESEARCH
COUNTRY SPECIFIC STUDIES
ABOUT CMI
SECTOR
COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS







Global Leading Equipment and System Manufacturers
Component Providers and System Integrators
Distributors, Retailors and Value Added Resellers
Healthcare IT Solutions Developers
Marketing Consultancies and the Advertising Industry
Private and Government organization
Outsourcing Companies
ABOUT US
KEY STATS
RESEARCH
SOLUTIONS
FEASIBILITY
STUDIES
GLOBAL
REPORTS
100+
Insights Published Per Year
150+
Consulting Projects Till Date
125+
Clients Worldwide Per Year
110+
COUNTRY
ANALYSIS
CONSULT
PROJECTS
SURVEY
RESEARCH
EXCEL
FORECAST
DATABASE
COMPETITIVE
ASSESSMENT
TECHNOLOGY
SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare,
and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports
across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique
—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our
clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities
posed therein.
THANK YOU
To know more about us, visit our website:
www.coherentmarketinsights.com
For sales queries or new topics email us on:
sales@coherentmarketinsights.com
For other queries contact:
Mr. Shah
(Manager - Business Development)
Coherent Market Insights
sales@coherentmarketinsights.com
+1-206-701-6702

Biologics market revenue is growing because of increasing number of Food and Drug Administration (FDA) approvals for new biologic medicines for treatment of rare diseases.